Torloni MR, Betran AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al
Once you have reached your ideal body weight, you can discontinue the GLP-1. Its also still unclear if the drugs make it into semen or breast milk, so they shouldnt be used while trying to conceive or breastfeeding
[74] Its interesting to note that Semaglutide (Ozempic ) has been approved for T2D and cardiovascular risk reduction but not yet for weight loss application
Tirzepatide injection specifics Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways rather than one
This decision should be based on response, side effects, hunger, weight trend, labs, and patient goals
Anyone who develops unwanted symptoms after starting should stop use and check with a qualified healthcare professional